Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Pastan

Showing results (21-30 of 340) with videos related to

Pageof 34
Sort By:
Biomolecules|November 27, 2021
Immunotoxins: From Design to Clinical ApplicationRobert J Kreitman, Ira Pastan
Hematology/Oncology Clinics of North America|September 23, 2006
Immunotoxins in the treatment of refractory hairy cell leukemiaRobert J Kreitman, Ira Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotoxRobert J Kreitman, Ira Pastan
Biomolecules|August 7, 2020
Development of Recombinant Immunotoxins for Hairy Cell LeukemiaRobert J Kreitman, Ira Pastan
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2006
Isolation of anti-CD22 Fv with high affinity by Fv display on human cellsMitchell Ho, Satoshi Nagata, Ira Pastan
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cellsXing Du, Mitchell Ho, Ira Pastan
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunityMasanori Onda, Kazuto Kobayashi, Ira Pastan
The Oncologist|January 7, 2015
Advances in anticancer immunotoxin therapyChristine Alewine, Raffit Hassan, Ira Pastan
Journal of Immunological Methods|September 16, 2003
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteinsSatoshi Nagata, Giuliana Salvatore, Ira Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Mesothelin: a new target for immunotherapyRaffit Hassan, Tapan Bera, Ira Pastan
Pageof 34

Showing results (21-30 of 340) with videos related to

Sort By:
Pageof 34
Biomolecules|November 27, 2021
Immunotoxins: From Design to Clinical ApplicationRobert J Kreitman, Ira Pastan
Hematology/Oncology Clinics of North America|September 23, 2006
Immunotoxins in the treatment of refractory hairy cell leukemiaRobert J Kreitman, Ira Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotoxRobert J Kreitman, Ira Pastan
Biomolecules|August 7, 2020
Development of Recombinant Immunotoxins for Hairy Cell LeukemiaRobert J Kreitman, Ira Pastan
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2006
Isolation of anti-CD22 Fv with high affinity by Fv display on human cellsMitchell Ho, Satoshi Nagata, Ira Pastan
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cellsXing Du, Mitchell Ho, Ira Pastan
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunityMasanori Onda, Kazuto Kobayashi, Ira Pastan
The Oncologist|January 7, 2015
Advances in anticancer immunotoxin therapyChristine Alewine, Raffit Hassan, Ira Pastan
Journal of Immunological Methods|September 16, 2003
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteinsSatoshi Nagata, Giuliana Salvatore, Ira Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Mesothelin: a new target for immunotherapyRaffit Hassan, Tapan Bera, Ira Pastan
Pageof 34